window.pageData = {"stock":{"_id":3000000024825,"name":"招商医药精选混合型发起式证券投资基金","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","status":"normal","stockCode":"024825","tickerId":24825,"shortName":"招商医药精选混合发起式C","currency":"CNY","exchange":"jj","masterFundFlag":null,"indexFundFlag":null,"activeFundFlag":null,"etfFundFlag":null,"lofFundFlag":null,"pensionTargetFlag":null,"feederFundFlag":null,"classificationFlag":null,"closedEnd":null,"inceptionDate":"2025-08-07T16:00:00.000Z","pinyin":"zsyyjxhhxfqszqtzjj","fundCollectionId":4000050210000,"fundCollection":{"exchange":"jjgs","stockType":"fund_collection","stockCode":"50210000","tickerId":50210000,"name":"招商基金管理有限公司"},"managers":[{"name":"梅梅","stockType":"fund_manager","stockCode":"j101020120","exchange":"fm","tickerId":1313255890}],"hotMetrics":{"fss":{"stockId":3000000024825,"type":"fss","last_data_date":"2025-12-30T16:00:00.000Z","f_ins_h_s_r":0,"f_ind_h_s_r":1,"f_h_a":302},"fpr":{"stockId":3000000024825,"type":"fpr","f_cagr_p_r_fs_ssc":9327,"f_cagr_p_r_fs_ssrp":0.9624705125455715,"f_p_r_m1_ssc":9399,"f_p_r_m1_ssrp":0.10214939348797616,"f_p_r_m3_ssc":9201,"f_p_r_m3_ssrp":0.47054347826086956,"f_p_r_fys_ssc":8926,"f_p_r_fys_ssrp":0.7043137254901961,"f_p_r_m6_ssc":8973,"f_p_r_m6_ssrp":0.6081141328577797},"fp":{"stockId":3000000024825,"type":"fp","last_data_date":"2026-07-27T16:00:00.000Z","f_cagr_p_r_fs":-0.12566871908751376,"f_p_r_m1":0.06517461878996533,"f_p_r_m3":-0.029685224599529048,"f_p_r_fys":-0.042767156591888456,"f_p_r_m6":-0.06950263186163874,"f_i_d":"2025-08-07T16:00:00.000Z"},"ff":{"stockId":3000000024825,"type":"ff","f_fr_d":"2026-07-26T16:00:00.000Z","f_m_fr":0.012,"f_c_fr":0.002,"f_mac_fr":0.014},"f_nlacan":{"stockId":3000000024825,"type":"f_nlacan","f_nv_d":"2026-07-27T16:00:00.000Z","f_nv":0.8662,"f_nv_cr":-0.030011198208286682},"f_as":{"stockId":3000000024825,"type":"f_as","f_tas":1814952.7812,"f_tas_d":"2026-06-29T16:00:00.000Z"}},"masterSlaveFunds":[{"_id":3000000024824,"__csrcFundId":15470,"stockCode":"024824","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":24824,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"招商医药精选混合发起式(024824)","lastUpdated":"2026-07-24T21:23:23.904Z","name":"招商医药精选混合型发起式证券投资基金","pinyin":"zsyyjxhhxfqszqtzjj","fundCollectionId":4000050210000,"setUpAssetScale":10384929.75,"setUpDate":"2025-08-04T16:00:00.000Z","setUpShares":10384929.75,"inceptionDate":"2025-08-07T16:00:00.000Z","followedNum":6,"masterFundShortName":"招商医药精选混合发起式"}],"shareholdings":[{"date":"2026-06-29T16:00:00.000Z","declarationDate":"2026-07-20T16:00:00.000Z","fundId":3000000024824,"stockId":688235,"holdings":3183,"marketCap":810423,"netValueRatio":0.0667,"quarterlyChange":0.0820654483637906,"stock":{"stockCode":"688235","tickerId":688235,"exchange":"sh","stockType":"company","name":"百济神州"}},{"date":"2026-06-29T16:00:00.000Z","declarationDate":"2026-07-20T16:00:00.000Z","fundId":3000000024824,"stockId":688796,"holdings":6421,"marketCap":702457,"netValueRatio":0.0578,"quarterlyChange":0.16506922257721035,"stock":{"name":"百奥赛图","exchange":"sh","stockType":"company","stockCode":"688796","tickerId":688796}},{"date":"2026-06-29T16:00:00.000Z","declarationDate":"2026-07-20T16:00:00.000Z","fundId":3000000024824,"stockId":2317,"holdings":28300,"marketCap":695331,"netValueRatio":0.0572,"quarterlyChange":0.32898264427825774,"stock":{"stockCode":"002317","exchange":"sz","stockType":"company","tickerId":2317,"name":"众生药业"}},{"date":"2026-06-29T16:00:00.000Z","declarationDate":"2026-07-20T16:00:00.000Z","fundId":3000000024824,"stockId":688202,"holdings":8538,"marketCap":689101,"netValueRatio":0.0567,"quarterlyChange":0.29342948717948825,"stock":{"stockCode":"688202","tickerId":688202,"exchange":"sh","stockType":"company","name":"美迪西"}},{"date":"2026-06-29T16:00:00.000Z","declarationDate":"2026-07-20T16:00:00.000Z","fundId":3000000024824,"stockId":1000000000006990,"holdings":1800,"marketCap":681950,"netValueRatio":0.0561,"quarterlyChange":-0.04300131636682747,"stock":{"exchange":"hk","stockType":"company","stockCode":"06990","tickerId":6990,"name":"科伦博泰生物"}},{"date":"2026-06-29T16:00:00.000Z","declarationDate":"2026-07-20T16:00:00.000Z","fundId":3000000024824,"stockId":688179,"holdings":21263,"marketCap":589197,"netValueRatio":0.0485,"quarterlyChange":0.6017341040462436,"stock":{"stockCode":"688179","tickerId":688179,"exchange":"sh","stockType":"company","name":"阿拉丁"}},{"date":"2026-06-29T16:00:00.000Z","declarationDate":"2026-07-20T16:00:00.000Z","fundId":3000000024824,"stockId":2422,"holdings":15100,"marketCap":581652,"netValueRatio":0.0479,"quarterlyChange":0.12498789650164,"stock":{"stockCode":"002422","exchange":"sz","stockType":"company","tickerId":2422,"name":"科伦药业"}},{"date":"2026-06-29T16:00:00.000Z","declarationDate":"2026-07-20T16:00:00.000Z","fundId":3000000024824,"stockId":1000000000001801,"holdings":6500,"marketCap":449387,"netValueRatio":0.037,"quarterlyChange":-0.07549361207897753,"stock":{"stockCode":"01801","exchange":"hk","stockType":"company","tickerId":1801,"name":"信达生物"}},{"date":"2026-06-29T16:00:00.000Z","declarationDate":"2026-07-20T16:00:00.000Z","fundId":3000000024824,"stockId":1000000000001276,"holdings":8800,"marketCap":442161,"netValueRatio":0.0364,"quarterlyChange":-0.11545975575895107,"stock":{"exchange":"hk","stockType":"company","stockCode":"01276","tickerId":1276,"name":"恒瑞医药"}},{"date":"2026-06-29T16:00:00.000Z","declarationDate":"2026-07-20T16:00:00.000Z","fundId":3000000024824,"stockId":688041,"holdings":1075,"marketCap":398072,"netValueRatio":0.0328,"quarterlyChange":0.7172921484503099,"stock":{"name":"海光信息","exchange":"sh","stockType":"company","stockCode":"688041","tickerId":688041}}],"bondHoldings":[{"_id":"6a5f56eb8cdf3996de5c18ff","date":"2026-06-29T16:00:00.000Z","declarationDate":"2026-07-20T16:00:00.000Z","fundId":3000000024824,"stockCode":"019785","stockName":"25国债13","holdings":1000,"marketCap":101262,"netValueRatio":0.0083,"lastUpdated":"2026-07-21T11:24:27.779Z"}]},"list":[{"_id":"6a5f4fc78cdf3996de5a6746","date":"2026-06-29T16:00:00.000Z","declarationDate":"2026-07-20T16:00:00.000Z","stockId":3000000024824,"sao":"2026年上半年，全球宏观与资本市场运行的核心特征，增长未失速，但结构性分化显著加剧；流动性未全面转向，但资产定价已从“宽松交易”切换至“景气验证”。全球范围内，科技资本开支、财政扩张与供应链重构，仍在支撑风险资产定价，但中东局势扰动、能源价格波动、美联储偏鹰预期抬升。国内经济二季度，呈现出口强、内需弱、固投集中下行的分化格局，稳增长政策仍待进一步落地。美股，在人工智能浪潮推动下强势上行，A股，延续震荡上行，但结构分化，以通信、电子为代表的TMT成为最大亮点，消费与医药持续承压，成长风格明显跑赢蓝筹。回顾上半年，创新药产业层面仍持续上行，国内创新药对外授权（BD）交易总额超900亿美金，约等于2025年全年的七成，且八到九成是跟跨国大药企的交易，体现出中国创新药出海的持续验证。同时，A股、港股超百家医药公司公布回购，体现出产业内部的信心。关于本基金的运作，报告期内，维持对创新药的重点配置，结合临床数据、业绩披露窗口，适时优化持仓结构。同时，与创新药相配套的研发外包服务、科研上游行业，有望受益于景气上行，着重配置经营确定性较强，且估值相对合理的优质公司。","lastUpdated":"2026-07-21T10:53:59.196Z","fund":{"_id":3000000024824,"__csrcFundId":15470,"stockCode":"024824","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":24824,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"招商医药精选混合发起式(024824)","lastUpdated":"2026-07-24T21:23:23.904Z","name":"招商医药精选混合型发起式证券投资基金","pinyin":"zsyyjxhhxfqszqtzjj","fundCollectionId":4000050210000,"setUpAssetScale":10384929.75,"setUpDate":"2025-08-04T16:00:00.000Z","setUpShares":10384929.75,"inceptionDate":"2025-08-07T16:00:00.000Z","followedNum":6,"masterFundShortName":"招商医药精选混合发起式","managers":[{"stockCode":"j101020120","stockType":"fund_manager","exchange":"fm","tickerId":1313255890,"name":"梅梅"}]},"announcement":{"linkText":"招商医药精选混合型发起式证券投资基金2026年第2季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1534439","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69e8eca81398d79843fea089","date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","stockId":3000000024824,"sao":"报告期内，全球宏观格局处于多重力量交汇的复杂状态。IMF最新预测将2026年全球增速上调至3.3%，但增长动能分化加剧，技术投资与财政扩张对冲了贸易摩擦的拖累，全球经济在\"脆弱韧性\"中运行。中东局势的急剧升级叠加供给端约束，能源与资源类周期板块，表现突出；高估值板块在全球流动性趋紧的背景下压力加大，科技板块内部出现分化，整体呈现从\"主题驱动\"向\"业绩验证\"过渡的特征。消费板块是表现最弱的方向之一，金融、地产板块同步走弱，反映市场对内需前景仍持谨慎态度。然而，医药板块持续兑现积极变化，一季度国内创新药对外授权（BD）交易总额超600亿美元，接近2025年全年的一半，出海势头明显提速。与此同时，AACR、ASCO学术会议即将召开，中国药企创新管线的临床数据披露，有望持续催化。关于本基金的运作，报告期内，维持对创新药的重点配置，结合学术会议节点与业绩披露窗口适时优化持仓结构。同时，会密切关注地缘局势对全球资产定价的重塑。","lastUpdated":"2026-04-22T15:43:36.539Z","fund":{"_id":3000000024824,"__csrcFundId":15470,"stockCode":"024824","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":24824,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"招商医药精选混合发起式(024824)","lastUpdated":"2026-07-24T21:23:23.904Z","name":"招商医药精选混合型发起式证券投资基金","pinyin":"zsyyjxhhxfqszqtzjj","fundCollectionId":4000050210000,"setUpAssetScale":10384929.75,"setUpDate":"2025-08-04T16:00:00.000Z","setUpShares":10384929.75,"inceptionDate":"2025-08-07T16:00:00.000Z","followedNum":6,"masterFundShortName":"招商医药精选混合发起式","managers":[{"stockCode":"j101020120","stockType":"fund_manager","exchange":"fm","tickerId":1313255890,"name":"梅梅"}]},"announcement":{"linkText":"招商医药精选混合型发起式证券投资基金2026年第1季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1474946","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69ce6662f45dd25f43f626e3","date":"2025-12-30T16:00:00.000Z","declarationDate":"2026-03-30T16:00:00.000Z","stockId":3000000024824,"sao":"2025年，全球经济整体延续弱复苏态势，增长格局分化，发达经济体普遍增长乏力。并且，美国加征“对等关税”，使其平均有效关税税率升至1934年以来最高水平，全球贸易体系遭遇冲击。反观国内，面对外部形势的挑战，2025年经济运行总体平稳，国内生产总值达到134.9万亿元，顺利完成5%的增长目标。A股市场，全年呈现整体上涨、结构分化的特征，科技、周期板块引领上涨，市场活跃度大幅提升。既反映了国内经济稳中有进的基本面，也体现了产业升级、科技赋能的发展趋势。从主要指数的表现来看，创业板指全年涨幅49.57%，沪深300指数全年涨幅17.66%，反映出市场对成长型资产的偏好，显著高于传统权重资产。关于本基金的运作，报告期内，基于对科技行业的相对看好，重点配置医药行业当中的新兴领域，包括创新药、创新器械等；同时，基于判断，新的消费内容，新的消费形式，新的消费技术落地等方向，有望存在大量新机遇，重点配置消费板块中，符合品质消费驱动的优质公司。","lastUpdated":"2026-04-02T12:51:46.023Z","mo":"全球不确定性仍在上升，包括美联储的货币政策、美元的弱势，2026年，全球资金再配置有望延续。结合国内偏重经济增长的态势，A股市场具备比较优势。2026年是“十五五”规划的开局之年，规划核心要求“以高质量发展为主题、以新质生产力为主线”，全年宏观经济，有望保持稳健复苏态势。政策方面，有望落实规划中“有效市场和有为政府相结合”的原则，实施更加积极的财政政策和适度宽松的货币政策，降低社会融资成本、激发市场主体活力。从中央经济工作会议的表态，预计房地产行业仍将起到托底作用。因此，预计制造业、科技、消费有望对经济产生关键作用，也有望带来较好投资机会。","fund":{"_id":3000000024824,"__csrcFundId":15470,"stockCode":"024824","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":24824,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"招商医药精选混合发起式(024824)","lastUpdated":"2026-07-24T21:23:23.904Z","name":"招商医药精选混合型发起式证券投资基金","pinyin":"zsyyjxhhxfqszqtzjj","fundCollectionId":4000050210000,"setUpAssetScale":10384929.75,"setUpDate":"2025-08-04T16:00:00.000Z","setUpShares":10384929.75,"inceptionDate":"2025-08-07T16:00:00.000Z","followedNum":6,"masterFundShortName":"招商医药精选混合发起式","managers":[{"stockCode":"j101020120","stockType":"fund_manager","exchange":"fm","tickerId":1313255890,"name":"梅梅"}]},"announcement":{"linkText":"招商医药精选混合型发起式证券投资基金2025年年度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1456933","linkType":"PDF","source":"csrc_pdf"}}]}